Somatic genomic rearrangements in human leucocyte antigens region in solid ovarian tumors

N. Hryshchenko, V. Gordiyuk, S. Kravchenko, S. Arbuzova, V. Kashuba
{"title":"Somatic genomic rearrangements in human leucocyte antigens region in solid ovarian tumors","authors":"N. Hryshchenko, V. Gordiyuk, S. Kravchenko, S. Arbuzova, V. Kashuba","doi":"10.7124/BC.000A50","DOIUrl":null,"url":null,"abstract":"The success of immunotherapy for ovarian cancer is determined by the effectiveness of the patient’s immune response, as well as the qualitative and quantitative representation of antigens of the main histocompatibility complex in tumor cells and microenvironment. The level of the HLA (Human Leukocyte Antigens) genes expression in tumor tissue does not always correctly reflect the expression of these genes in different populations of tumor cells. Aim. To analyze the frequency and range of somatic deletions and duplications in the HLA locus. Methods. LOH-analysis (Loss of Heterozyhosity) of the STR-markers (Short Tandem Repeats) in the ovarian tumors of affected patients. Results. We have shown that complex somatic genomic reorganizations, involving several HLA loci, are quite common in ovarian tumors. The detected genetic alterations vary by both the type (deletions and mutations in STR alleles) and proportion of the sub-population of cells with the alterations. Conclusion. The results obtained allow us to propose the LOH-analysis for highly effective detection of aneuploidy and different types of somatic genomic reorganizations in the HLA region even in minor cell populations. This analysis provides the additional prognostic information for predic ting the effectiveness of different types of ovarian cancer immunotherapy at the indi vidual level.","PeriodicalId":9017,"journal":{"name":"Biopolymers & Cell","volume":"1 1","pages":"105-116"},"PeriodicalIF":0.0000,"publicationDate":"2021-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biopolymers & Cell","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.7124/BC.000A50","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The success of immunotherapy for ovarian cancer is determined by the effectiveness of the patient’s immune response, as well as the qualitative and quantitative representation of antigens of the main histocompatibility complex in tumor cells and microenvironment. The level of the HLA (Human Leukocyte Antigens) genes expression in tumor tissue does not always correctly reflect the expression of these genes in different populations of tumor cells. Aim. To analyze the frequency and range of somatic deletions and duplications in the HLA locus. Methods. LOH-analysis (Loss of Heterozyhosity) of the STR-markers (Short Tandem Repeats) in the ovarian tumors of affected patients. Results. We have shown that complex somatic genomic reorganizations, involving several HLA loci, are quite common in ovarian tumors. The detected genetic alterations vary by both the type (deletions and mutations in STR alleles) and proportion of the sub-population of cells with the alterations. Conclusion. The results obtained allow us to propose the LOH-analysis for highly effective detection of aneuploidy and different types of somatic genomic reorganizations in the HLA region even in minor cell populations. This analysis provides the additional prognostic information for predic ting the effectiveness of different types of ovarian cancer immunotherapy at the indi vidual level.
实体卵巢肿瘤中人白细胞抗原区体细胞基因组重排
卵巢癌免疫治疗的成功取决于患者免疫反应的有效性,以及肿瘤细胞和微环境中主要组织相容性复合体抗原的定性和定量表征。HLA(人类白细胞抗原)基因在肿瘤组织中的表达水平并不总是正确地反映这些基因在不同肿瘤细胞群中的表达。的目标。分析HLA基因座中体细胞缺失和重复的频率和范围。方法。卵巢肿瘤患者str标记(短串联重复序列)的杂合性缺失(loh)分析。结果。我们已经表明,复杂的体细胞基因组重组,涉及几个HLA位点,是相当常见的卵巢肿瘤。检测到的遗传改变因类型(STR等位基因的缺失和突变)和具有改变的细胞亚群的比例而异。结论。所得结果使我们能够提出loh分析,用于高效检测HLA区域的非整倍体和不同类型的体细胞基因组重组,甚至在次要细胞群体中也是如此。该分析为预测不同类型卵巢癌免疫治疗在个体水平上的有效性提供了额外的预后信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信